Tests an AI eye exam for diabetic eye disease in young people with diabetes
Tests an AI eye camera exam for diabetic eye damage in youth with diabetes.
Plain-language title generated from the registry record
Registry title: ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Key facts
- Where
- Baltimore, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 21 years old?
Source: NCT05463289, who can take part
Where in United States
- Johns Hopkins Pediatric Diabetes CenterBaltimore, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Johns Hopkins University
- Trial code
- NCT05463289
- Record updated
- 23 September 2026
- Original description
The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the autonomous AI system in detecting diabetic retinopathy from retinal images of youth with diabetes.Read full original descriptionShow less
Implementing Digital Retinal Exams Into Comprehensive Pediatric Diabetes Care
The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy, and to determine the diagnostic accuracy of the autonomous AI system in detecting diabetic retinopathy from retinal images of youth with diabetes.
Inclusion: Meets American Diabetes Association (ADA) criteria for diabetic retinopathy screening:; Diagnosis of Type 1 diabetes for ≥3 years, and age 11 or in puberty; Diagnosis of Type 2 diabetes; Enriched cohort:; Patients with Type 1 or Type 2 diabetes,; 8-21 years of age with known diabetic retinopathy (true positives); No time limit on last diabetic eye exam.
Exclusion: Known diabetic eye exam in the last 12 months.